SCIENTIFIC PROGRAMME GRAND BALLROOM DAY 1 - SATURDAY, 26TH SEPTEMBER 2015 Chairs: Nguyen Anh Tri, Vip Viprakasit 08:30 – 08:55 - Overview of Transfusion Dependent Thalassaemia management (TDT) - Chi Kong Li 08.30 - 10.00
Symposium 1: Treatment updates
08:55 – 09:20 - Overview of Non-Transfusion Dependent Thalassaemia management (NTDT) - Anuja Premawardhena 09:20 – 09:45 - Haematopoietic Stem Cell Transplantation (HSCT) current progress - Suradej Hongeng 09:45 – 10:00 - Panel Discussion
10.00 - 10.30
Coffee
Satellite: Blood safety Symposium
10.30 - 12.30
Chairs: Androulla Eleftheriou/ Aparna Singh Shah/Erica Wood 10:30 – 10:55 - Blood adequacy and safety – Challenges in the Asian Region - Aparna Singh Shah 10:55 – 11:15 - Blood adequacy, safety and recruitment: the Vietnam model – Ngo Manh Quan 11:15 – 11:40 - Blood safety international standards-the Australian Model – Erica Wood 11:40 – 12:05 - Blood transfusion in Thalassaemia – Cheuk Kwong Lee 12:05 – 12:30 - Mitigating infectious risks in transfusion practice – Yesim Aydinok
12.30 – 14.00
Lunch Chairs: Bach Quoc Khanh/Suthat Fucharoen Presentations selected from submitted abstracts: 14:00 – 14:06 – α- Thalassaemia: The Maldivian story - Zileena Zahir 14:06 – 14:12 – α-Thalassaemia Gene Mutations in neonates from Mazandaran, Iran (2012) - Hossein Jalali 14:12 – 14:18 - Sanguinate™ as a Therapeutic Agent for thalassaemia - Kittiphong Paiboonsukwong 14:18 – 14:24 – Prevalence of Alloimmunization in Major Beta Thalassaemia in Northern Iran (2010) - Kosaryan Mehrnoush
14.00 - 15.00
Free oral presentations
14:24 – 14:30 – Efficacy and Safety of Deferasirox in single vs divided dosage in Thalassaemic Children - Arsha Kalra 14:30 – 14:36 – Evaluation of iron overload in Thalassaemia patients – Nguyen Thi Thu Há 14:36 – 14:42 – Endocrine Complications in patients with Transfusion-Dependent Thalassaemia after Haematopoietic Stem Cell Transplantation - WingShan Queenie See 14:42 – 14:48 - Haematopoietic stem cell transplant (HSCT) outcome for thalassemia major in Amirkola Bone Marrow Transplantation (B.M.T) ward - Ahmad Tamaddoni 14:48 – 14:54 – Factors affecting physical, emotional and social Health related quality of life of patients who are more than 12 years and diagnosed with BETAThalassaemia - MBKC Dayasiri 14:54 – 15:00 – Thalassaemia micro-particles induced platelets activation - Saovaros Svasti
15.00 - 15.30
Coffee Chairs: Androulla Eleftheriou/Suthat Fucharoen Country report presentations:
15.30 - 17.00
Country reports
15:30 – 15:39 - Sri Lanka – Anuja Premawardhena 15:39 – 15:48 - Malaysia - Mohamed Ibrahim Hishamshah 15:48 – 15:57 - India – Roshan Colah 15:57 – 16:06 - Indonesia - Pustika Amalia Wahidiyat
16:06 – 16:15 - Philippines – Maria Liza Naranjo 16:15 – 16:24 - Bangladesh – Mahmood Chowdhury (Arzu) 16:24 – 16:33 - Vietnam - Nguyen Anh Tri 16:33 – 16:42 - Myanmar – Sein Win 16:42 – 16:51 - People’s Republic of China – Chen Ping 16:51 – 17:00 - Panel Discussion Chair : Nguyen Anh Tri 17:00 – 17:05 - Welcome and introduction – Nguyen Anh Tri
17.00 – 18.00
Novartis Oncology Satellite Symposium
17:05 – 17:30 - Optimal Management of iron overload: targeting the liver, heart and beyond – Vip Viprakasit 17:30 – 17:55 - Establishing a comprehensive thalassaemia care programme: successes and challenges – Ibrahim Mohamed Hishamshah 17:55 – 18:00 - Questions and Answers Facilitators: Nguyen Binh Minh/ Le Thanh Hang TIF – Panos Englezos NIHBT/ViTA – Nguyen Anh Tri Ministry of Health of Vietnam
18.00 - 20.00
Opening ceremony
Key Note Presentations: Haemoglobin Disorders: Access to care and prevention: The global picture - Androulla Eleftheriou Gene Therapy – Philippe Leboulch Traditional Music Show – 20 minutes
DAY 2 - SUNDAY, 27TH SEPTEMBER 2015 Chair: John B. Porter/Vip Viprakasit 08:30 – 08:55 - Iron metabolism and iron load in Haemoglobin disorders – Vip Viprakasit 08.30 - 10.00
Symposium 3: Iron
08:55 – 09:20 - Iron chelation in Transfusion Dependent Thalassaemia (TDT) – John B. Porter 09:20 – 09:45 - Iron chelation in Non-Transfusion Dependent Thalassaemias (NTDT) – Ibrahim Mohamed Hishamshah 09:45 – 10:00 - Panel discussion
10.00 - 10.30
Coffee Chair: Shau Yin Ha/ Dimitrios Kountouras 10:30 – 10:55 - Liver Disease: Viral Hepatitis: Treat or Cure – Dimitrios Kountouras
10.30 - 12.30
Symposium 4: Common complications – disease and treatment related
10:55 – 11:20 - Heart Complications – Athanassios Aessopos 11:20 – 11:45 - Endocrine complications – Shau Yin Ha 11:45 – 12:10 - Infections – Suthat Fucharoen 12:10 – 12:30 - Silent cerebral ischaemia in Transfusion Dependent Thalassaemia (TDT) patients – Mehran Karimi
12.30 - 14.00
Lunch Chairs: Bach Quoc Khanh/Philippe Leboulch 14:00 – 14:20 - Safety and Efficacy of Oral Therapy with Grazoprevir and Elbasvir for Chronic Hepatitis C – Paul Kwo 14:20 – 14:40 - MRI Technologies for Measurement of Tissue Iron Concentrations – Tim St Pierre
14.00 - 15.45
Symposium 5: New Advances
14:40 – 15:00 - MRI – The Thai experience – Pairash Saiviroonporn 15:00 – 15:20 - Novel Erythropoiesis Stimulating Agents In Thalassemia – John B. Porter 15:20 – 15:35 - Haematopoietic Stem Cell Transplantation (HSCT) – The South China Experience - Huaying Liu 15:35 – 15:45 - Panel Discussion
15.45 - 16.15
Coffee Chairs: Roshan Colah/ Michael Angastiniotis 16:15 – 16:35 - Screening and Counselling – Roshan Colah
16.15 - 17.30
Symposium 6: Prevention
16:35 – 16:55 - Obstetric approaches – Chanane Wanapirak 16:55 – 17:15 - Pre-implantation Genetic Diagnosis (PGD) – Wirawit Piyamongkol 17:15 – 17:30 – Panel Discussion Chairs: Michael Angastiniotis/ Androulla Eleftheriou 17:30 – 17:50 - Epidemiology studies of the thalassaemia syndromes in Asia – Fred Piel
17.30 - 18.50
Symposium 7: Public health issues
17:50 – 18:10 - Health technology assessment - Ying Yao Chen 18:10 – 18:30 - Generic or Substandard Drugs – Mahmood Hadipour Dehshal 18:30 – 18:50 – Panel Discussion Panos Englezos, Nguyen Anh Tri, John B. Porter, Androulla Eleftheriou and Suthat Fucharoen
18.50 – 19.15
Closing remarks and Way forward “Signing of a Joint Declaration”